Xufu Wang

730 total citations
41 papers, 498 citations indexed

About

Xufu Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Xufu Wang has authored 41 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Xufu Wang's work include Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (9 papers) and Thyroid Disorders and Treatments (6 papers). Xufu Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (9 papers) and Thyroid Disorders and Treatments (6 papers). Xufu Wang collaborates with scholars based in China, Poland and United States. Xufu Wang's co-authors include Guo‐Ming Wang, Xinfeng Liu, Jiawei Xie, Chenghui Lu, Guoqiang Wang, Zenghua Wang, Chao Ma, Qin Zhang, Qingbo Yang and Chao Ma and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Endocrinology.

In The Last Decade

Xufu Wang

36 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufu Wang China 12 182 105 97 76 67 41 498
Willieford Moses United States 11 410 2.3× 74 0.7× 221 2.3× 32 0.4× 84 1.3× 16 596
Le Zhou China 14 66 0.4× 61 0.6× 144 1.5× 51 0.7× 368 5.5× 50 671
Meng-Chi Chen China 12 88 0.5× 22 0.2× 122 1.3× 37 0.5× 116 1.7× 19 489
Akihito Hiura Japan 13 101 0.6× 100 1.0× 379 3.9× 32 0.4× 128 1.9× 36 577
Guanhua Xue China 13 89 0.5× 34 0.3× 163 1.7× 127 1.7× 160 2.4× 36 616
Hannele Ylipahkala Finland 8 64 0.4× 302 2.9× 60 0.6× 34 0.4× 414 6.2× 10 729
Toshihiko Yokota Japan 12 112 0.6× 27 0.3× 17 0.2× 56 0.7× 60 0.9× 40 389
Lichu Liu United States 16 75 0.4× 154 1.5× 88 0.9× 24 0.3× 334 5.0× 29 689
Anthony P. Trace United States 8 76 0.4× 57 0.5× 323 3.3× 36 0.5× 248 3.7× 18 705
Xiuli Zhang China 13 19 0.1× 68 0.6× 131 1.4× 67 0.9× 95 1.4× 49 497

Countries citing papers authored by Xufu Wang

Since Specialization
Citations

This map shows the geographic impact of Xufu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufu Wang more than expected).

Fields of papers citing papers by Xufu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufu Wang. The network helps show where Xufu Wang may publish in the future.

Co-authorship network of co-authors of Xufu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xufu Wang. A scholar is included among the top collaborators of Xufu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufu Wang. Xufu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Chenghui, Xufu Wang, Jiao Li, et al.. (2025). Selective Therapeutic Potential of a H2O2-Inducible DNA Interstrand Cross-linker in Anaplastic Thyroid Carcinoma. Endocrinology. 166(4). 1 indexed citations
3.
Sun, Di, Jiao Li, Chenghui Lu, et al.. (2025). Reflective analysis on the current 131I adjuvant therapy indications in intermediate- and high-risk differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3125–3134. 1 indexed citations
4.
5.
Lu, Chenghui, Na Han, Jiao Li, et al.. (2024). Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study. Heliyon. 10(6). e27736–e27736. 2 indexed citations
6.
Chen, Chang, et al.. (2023). Preparation and characterization of modified activated carbon-based shape stabilized eutectic phase change materials for gypsum composites application. Construction and Building Materials. 369. 130551–130551. 22 indexed citations
7.
Chen, Chang, et al.. (2023). Effect of rock-wool waste on physical, mechanical, and microscopic properties of nonburn solid bricks. Construction and Building Materials. 392. 131805–131805. 8 indexed citations
8.
Wang, Congcong, Gai‐Xia Lu, Yutian Li, et al.. (2023). Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy. Frontiers in Endocrinology. 14. 1217092–1217092. 3 indexed citations
9.
10.
Lu, Chenghui, Congcong Wang, Fengqi Li, et al.. (2022). The influence of stimulated thyroglobulin and lymphocyte subsets before radioiodine therapy on the therapeutic response in patients with intermediate- and high-risk papillary thyroid carcinoma. Clinical and Experimental Medicine. 23(6). 2193–2200. 3 indexed citations
11.
Wang, Xufu, Guoqiang Wang, Zenghua Wang, et al.. (2019). PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1/PD-L1-dependent pathway. Molecular Immunology. 109. 20–26. 99 indexed citations
12.
Wang, Chen, et al.. (2018). Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma. Frontiers in Oncology. 8. 640–640. 9 indexed citations
13.
Wang, Yujun, et al.. (2017). Treatment of Graves' ophthalmopathy with an in-house Phosphorus-32 source: Initial clinical observations. Experimental and Therapeutic Medicine. 14(4). 2795–2800. 3 indexed citations
14.
Lu, Chenghui, Xufu Wang, Bin Liu, et al.. (2017). Application values of 99mTc-methoxyisobutylisonitrile imaging for differentiating benign and malignant thymic masses. Oncology Letters. 14(2). 2417–2421.
15.
Wang, Zenghua, et al.. (2017). Superior mediastinal typical carcinoid detected by 99mTc-MIBI SPECT/CT imaging. Medicine. 96(52). e9457–e9457. 2 indexed citations
16.
17.
Wang, Zhenguang, et al.. (2013). Dynamical Observation on Biological Progression of VX2 Liver Tumors to Identify the Optimal Time for Intervention in Animal Models. PLoS ONE. 8(8). e74327–e74327. 7 indexed citations
18.
Yang, Guangjie, et al.. (2011). Tc-99m MDP Uptake in a Giant Pulmonary Chondroma. Clinical Nuclear Medicine. 36(11). 1029–1030. 11 indexed citations
19.
20.
Wang, Xufu. (2004). 131)I therapy of inoperable lymph node metastases from differentiated thyroid cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willieford Moses Breakdown of academic impact, for papers by Le Zhou Breakdown of academic impact, for papers by Meng-Chi Chen Breakdown of academic impact, for papers by Akihito Hiura Breakdown of academic impact, for papers by Guanhua Xue Breakdown of academic impact, for papers by Hannele Ylipahkala Breakdown of academic impact, for papers by Toshihiko Yokota Breakdown of academic impact, for papers by Lichu Liu Breakdown of academic impact, for papers by Anthony P. Trace Breakdown of academic impact, for papers by Xiuli Zhang
Rankless by CCL
2026